Concordance of PD-L1 status in primary gastroesophageal adenocarcinoma and matched peritoneal metastases: a single institution study
Authors:
- V. MassaVMV. Massa
- F. SignoriniFSF. Signorini
- F. SalaniFSF. Salani
- M.E. FiliceMFM.E. Filice
- G. GrelliGGG. Grelli
- P. LippolisPLP. Lippolis
- P. FavianaPFP. Faviana
- V. GenovesiVGV. Genovesi
- S. SantiSSS. Santi
- C. VivaldiCVC. Vivaldi
- S. CesarioSCS. Cesario
- A. BertolucciABA. Bertolucci
Open Access
- 19 August 2024
- journal article
- Published by Elsevier in ESMO Gastrointestinal Oncology
- Vol. 5
Abstract
No abstract availableKeywords
Funding Information
- University of Pisa
This publication has 28 references indexed in Scilit:
- Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trialThe Lancet Oncology, 2023
- Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trialThe Lancet, 2023
- Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to actionGastric Cancer, 2023
- Association of PD-L1 Expression and Other Variables With Benefit From Immune Checkpoint Inhibition in Advanced Gastroesophageal CancerJAMA Oncology, 2022
- Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapyGastric Cancer, 2022
- The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling studyeClinicalMedicine, 2022
- Prognostic factors to predict the survival in patients with advanced gastric cancer who receive later‐line nivolumab monotherapy—The Asahikawa Gastric Cancer Cohort Study (AGCC)Cancer Medicine, 2021
- Discordancy and changes in the pattern of programmed death ligand 1 expression before and after platinum-based chemotherapy in metastatic gastric cancerGastric Cancer, 2018
- Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based studyThe Lancet Oncology, 2014
- Peritoneal-plasma barrier1996